COMBINACION DE INHIBIDORES DE MTP E INHIBIDORES DE HMG-COA REDUCTASA Y SU USO EN MEDICAMETOS

La invención se refiere al use de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención. The inven...

Full description

Saved in:
Bibliographic Details
Main Authors RUDI GRUTZMANN, ULRICH MULLER, HILMA BISCHOFF
Format Patent
LanguageSpanish
Published 15.08.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract La invención se refiere al use de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención. The invention relates to the use of a combination consisting of at least one selected MTP inhibitor (constituent A) and of at least one HMG-CoA reductase inhibitor (constituent B) for fighting cardiovascular diseases. The invention also relates to medicaments containing this combination and to the production thereof.
AbstractList La invención se refiere al use de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención. The invention relates to the use of a combination consisting of at least one selected MTP inhibitor (constituent A) and of at least one HMG-CoA reductase inhibitor (constituent B) for fighting cardiovascular diseases. The invention also relates to medicaments containing this combination and to the production thereof.
Author RUDI GRUTZMANN
ULRICH MULLER
HILMA BISCHOFF
Author_xml – fullname: RUDI GRUTZMANN
– fullname: ULRICH MULLER
– fullname: HILMA BISCHOFF
BookMark eNrjYmDJy89L5WSIcfb3dfL0c3T29PdTcHFV8PTz8HTydPEPcg0GcX1DAhQwBD183XWd_R0VglxdQp1DHIMdFSIVgkMVQoP9FVz9FHxdXTydHX1dQ_yDeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvIt_gJEBBBgZORoTpwoAVlI0Fg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID DOP2000000022A
GroupedDBID EVB
ID FETCH-epo_espacenet_DOP2000000022A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_DOP2000000022A3
Notes Application Number: DO20000000022
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080815&DB=EPODOC&CC=DO&NR=P2000000022A
ParticipantIDs epo_espacenet_DOP2000000022A
PublicationCentury 2000
PublicationDate 20080815
PublicationDateYYYYMMDD 2008-08-15
PublicationDate_xml – month: 08
  year: 2008
  text: 20080815
  day: 15
PublicationDecade 2000
PublicationYear 2008
RelatedCompanies BAYER AKTIENGESELLSCHAFT
RelatedCompanies_xml – name: BAYER AKTIENGESELLSCHAFT
Score 2.5912123
Snippet La invención se refiere al use de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMBINACION DE INHIBIDORES DE MTP E INHIBIDORES DE HMG-COA REDUCTASA Y SU USO EN MEDICAMETOS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080815&DB=EPODOC&locale=&CC=DO&NR=P2000000022A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhT1DedytQpAaVvxfVr3R6KdElnJ7QpaycThNGvgSDbsBX_vpdu04GwPCUXOJIjd5dL7gPg3uxkitbNcrmXp7qMGj-VEzzGspa3M91MDCWuSid4fscd688TY1KDj00sTJUn9LtKjogclSK_l5W8Xv49YrHKt7J4SN4RtHgcRBaTNtaxqCNhSKxvOQFnnEqUWoxL_sgK1Paqqaq9B_t4kTYFPzgvfRGXstxWKoMTOAgQ37w8hVpeNOCIbmqvNeDQW395Y3fNfcUZvFHu9Ye-TVH-EeaQoe8OUdJyJKIYelFA_gFd70mm3CYjUWInskObvJJwTMYhJ45PVskdPSfi4TncDZyIujIuc_pLlSnj23vSLqA-X8zzJhBTyTrCTFHiWNNNLe32kljpptlMJOvT1dkltHZhuto9fQ3HK5cJND6NFtTLz6_8BvVymdxW5PwBCyCHbg
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhTnG86FT-mBpS-FdevdXso0iWdrS5NWTuZIIx-DQTZhqv49026TQfC8pRc4EiO3F0uuQ-AO7OVKVo7y-VOnuoy1_ipnPBjLGt5M9PNxFDisnQC9VvuUH8aGaMKfKxjYco8od9lckTOUSnn96KU1_O_RyxS-lYu7pN3Dpo99CKLSGvrWNSRMCTStZyAEYYljC3CJH9gBWpz2VTV3oFdfsk2BT84L10RlzLfVCq9Q9gLOL5pcQSVfFGHGl7XXqvDPl19efPuivsWx_CGGe16vo25_EPEQZ7velzSMk5EMaRRgP4BXfooY2ajgSixE9mhjV5ROETDkCHHR8vkjtSJWHgCtz0nwq7Mlzn-pcqYsM09aadQnc6m-RkgU8lawkxR4ljTTS1td5JYaafZRCTr09XJOTS2YbrYPn0DNTei_XHf858v4WDpPsENUaMB1eLzK7_iOrpIrkvS_gCRl4ph
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMBINACION+DE+INHIBIDORES+DE+MTP+E+INHIBIDORES+DE+HMG-COA+REDUCTASA+Y+SU+USO+EN+MEDICAMETOS&rft.inventor=RUDI+GRUTZMANN&rft.inventor=ULRICH+MULLER&rft.inventor=HILMA+BISCHOFF&rft.date=2008-08-15&rft.externalDBID=A&rft.externalDocID=DOP2000000022A